What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
Edward S. Friedman spends much of his time researching Cognitive therapy, Psychiatry, Depression, Internal medicine and Cognitive behavioral therapy.
His Cognitive therapy research is multidisciplinary, incorporating elements of Major depressive disorder, Severity of illness and Clinical psychology.
The Venlafaxine, Mania, Hypomania and Mood research Edward S. Friedman does as part of his general Psychiatry study is frequently linked to other disciplines of science, such as Bupropion, therefore creating a link between diverse domains of science.
His Depression research is multidisciplinary, incorporating perspectives in Psychosocial, Pediatrics and Risk factor.
He works in the field of Internal medicine, namely Discontinuation.
His studies deal with areas such as Schedule for Affective Disorders and Schizophrenia and Glucocorticoid as well as Cognitive behavioral therapy.
His most cited work include:
- Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression (696 citations)
- Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. (251 citations)
- Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. (233 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Psychiatry, Bipolar disorder, Depression, Internal medicine and Clinical psychology.
As a part of the same scientific study, Edward S. Friedman usually deals with the Psychiatry, concentrating on Randomized controlled trial and frequently concerns with Clinical trial.
Edward S. Friedman combines subjects such as Quetiapine, Comparative effectiveness research, Lithium and Mood with his study of Bipolar disorder.
His research in Depression focuses on subjects like Anxiety, which are connected to Quality of life.
His research in the fields of Severity of illness, Adverse effect and Discontinuation overlaps with other disciplines such as In patient.
His Clinical psychology research integrates issues from Psychological intervention, Outpatient clinic, Treatment outcome, Cognition and Social support.
He most often published in these fields:
- Psychiatry (53.47%)
- Bipolar disorder (45.54%)
- Depression (38.61%)
What were the highlights of his more recent work (between 2015-2021)?
- Bipolar disorder (45.54%)
- Quetiapine (15.84%)
- Depression (38.61%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Bipolar disorder, Quetiapine, Depression, Mood and Clinical psychology.
Bipolar disorder is a subfield of Psychiatry that Edward S. Friedman explores.
His work on Substance abuse is typically connected to Suicidal ideation as part of general Psychiatry study, connecting several disciplines of science.
His Quetiapine research focuses on subjects like Physical therapy, which are linked to Binge eating, Adjunctive treatment, Anthropometry and Waist.
His biological study spans a wide range of topics, including Endocrinology, Obesity, Mood disorders and Abdominal obesity.
While the research belongs to areas of Clinical psychology, he spends his time largely on the problem of Severity of illness, intersecting his research to questions surrounding Prospective cohort study and Quality of life.
Between 2015 and 2021, his most popular works were:
- Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder (45 citations)
- Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder (30 citations)
- Poor quality of life and functioning in bipolar disorder. (26 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
His primary areas of study are Bipolar disorder, Mood, Quetiapine, Clinical psychology and Anxiety.
Edward S. Friedman has begun a study into Bipolar disorder, looking into Depression and Psychiatry.
Edward S. Friedman has included themes like Substance abuse and Quality of life in his Depression study.
His work focuses on many connections between Anxiety and other disciplines, such as Randomized controlled trial, that overlap with his field of interest in Adverse effect.
His research in Severity of illness intersects with topics in Body mass index and White blood cell.
The various areas that Edward S. Friedman examines in his Internal medicine study include Endocrinology and Mood stabilizer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
